Prof Ahmed Badheeb

Prof Ahmed Badheeb

Speaker
Day: Day 1
Time: 8:30am – 8:40am

An Open-Label Randomized Active-Controlled
Phase II Clinical Study to Assess the Efficacy & Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (PROFECTA-II/GOG-3044)

Scroll to Top